X-linked Dominant Hypophosphatemic Rickets: A Comprehensive Guide

Overview

X-linked dominant hypophosphatemic rickets (XLH) is a rare, inherited disorder that affects the body's ability to regulate phosphate levels, leading to soft and weak bones. It is the most common form of hereditary rickets, occurring in approximately 1 in 20,000 to 1 in 25,000 live births (Source: NIH Genetic and Rare Diseases Information Center).

XLH primarily affects the bones, teeth, and kidneys. It is caused by mutations in the PHEX gene (phosphate-regulating endopeptidase homolog, X-linked), which disrupts the balance of phosphate and vitamin D in the body. Unlike other forms of rickets, XLH is not caused by a deficiency in vitamin D or calcium.

Who it affects: XLH affects both males and females, but symptoms are often more severe in males. The condition is present from birth, but symptoms may not become apparent until early childhood.

Symptoms

Symptoms of XLH vary in severity and may include:

• Bone deformities: Bowing of the legs (genu varum) or knocking of the knees (genu valgum) is common. Children may develop a waddling gait due to skeletal abnormalities.
• Short stature: Affected individuals often have disproportionate short stature, with shorter legs compared to the torso.
• Dental abnormalities: Delayed tooth eruption, abscesses, and poor enamel formation are frequent. Adults may experience early tooth loss.
• Bone pain and fractures: Chronic bone pain, especially in the legs, and an increased risk of fractures due to weakened bones.
• Muscle weakness: Reduced muscle strength and endurance, leading to fatigue and difficulty with physical activities.
• Joint stiffness: Stiffness or pain in joints, particularly the hips and knees, due to abnormal bone growth.
• Skull abnormalities: In some cases, the skull may appear enlarged or misshapen due to abnormal bone growth.
• Hearing loss: Some individuals may develop hearing impairment due to abnormalities in the bones of the ear.

Symptoms often appear in early childhood, typically between 1 and 2 years of age, when children begin to walk. However, some individuals may not be diagnosed until adulthood, especially if symptoms are mild.

Causes and Risk Factors

XLH is caused by mutations in the PHEX gene, located on the X chromosome. This gene plays a critical role in regulating phosphate levels in the body by controlling the production of a hormone called fibroblast growth factor 23 (FGF23). In XLH, excessive FGF23 leads to:

• Increased phosphate excretion by the kidneys (hypophosphatemia).
• Reduced activation of vitamin D, which impairs calcium absorption in the intestines.

As a result, bones do not mineralize properly, leading to soft, weak bones (rickets in children and osteomalacia in adults).

Inheritance Pattern

XLH follows an X-linked dominant inheritance pattern:

• Females (who have two X chromosomes) with one mutated PHEX gene will develop XLH because the normal gene cannot compensate for the mutation.
• Males (who have one X and one Y chromosome) with the mutated PHEX gene will also develop XLH, often with more severe symptoms.

If a mother carries the mutated gene, each of her children has a 50% chance of inheriting the condition. If a father has XLH, all his daughters will inherit the mutated gene, but none of his sons will (since they inherit the Y chromosome).

Risk Factors

The primary risk factor for XLH is having a family history of the condition. However, in some cases, XLH can occur due to a spontaneous (de novo) mutation in the PHEX gene, meaning neither parent carries the mutation.

Diagnosis

Diagnosing XLH involves a combination of clinical evaluation, laboratory tests, imaging studies, and genetic testing.

Clinical Evaluation

A healthcare provider will review the patient's medical history, family history, and perform a physical examination to assess:

• Bone deformities (e.g., bowing of the legs).
• Growth patterns and short stature.
• Dental abnormalities.
• Signs of muscle weakness or joint stiffness.

Laboratory Tests

Blood and urine tests are essential for diagnosing XLH:

• Serum phosphate levels: Typically low (hypophosphatemia).
• Serum calcium levels: Usually normal (unlike other forms of rickets).
• Alkaline phosphatase (ALP): Often elevated due to increased bone turnover.
• FGF23 levels: Elevated in XLH (though this test is not always available).
• Vitamin D levels: May be low or normal, but the active form (1,25-dihydroxyvitamin D) is often low.
• Urine phosphate levels: Increased due to excessive excretion.

Imaging Studies

X-rays and other imaging techniques help assess bone abnormalities:

• X-rays: May show bowing of the legs, widening of the growth plates (rachitic changes), or other skeletal deformities.
• Dual-energy X-ray absorptiometry (DEXA): Measures bone mineral density, which is often reduced in XLH.

Genetic Testing

Genetic testing for mutations in the PHEX gene can confirm the diagnosis of XLH. This is particularly useful for:

• Families with a history of XLH.
• Individuals with ambiguous laboratory or clinical findings.
• Prenatal diagnosis in families with a known PHEX mutation.

Treatment Options

While there is no cure for XLH, treatment aims to correct phosphate and vitamin D imbalances, improve bone health, and manage symptoms. Treatment typically involves a combination of medications, supplements, and lifestyle modifications.

Medications and Supplements

• Phosphate supplements: Oral phosphate is given multiple times a day to increase phosphate levels in the blood. Examples include neutral phosphorus (e.g., K-Phos).
• Active vitamin D analogs: These help improve calcium absorption and reduce FGF23 activity. Common options include:
  • Calcifediol (25-hydroxyvitamin D).
  • Calcitriol (1,25-dihydroxyvitamin D).
• Burosumab (Crysvita): A monoclonal antibody approved by the FDA in 2018 for XLH in children and adults. Burosumab blocks FGF23, improving phosphate reabsorption in the kidneys. It is administered as a subcutaneous injection every 2–4 weeks.

Surgical Interventions

In severe cases, surgical correction may be necessary to address:

• Bone deformities: Osteotomies (bone-cutting procedures) to correct bowing of the legs or other skeletal abnormalities.
• Dental issues: Treatment of abscesses, orthodontic care, or dental implants for missing teeth.
• Joint problems: Joint replacement or other orthopedic surgeries for severe arthritis.

Lifestyle and Supportive Care

• Physical therapy: Helps improve muscle strength, flexibility, and mobility.
• Orthopedic supports: Braces or shoe inserts may help with walking and reduce pain.
• Pain management: Over-the-counter pain relievers (e.g., acetaminophen or NSAIDs) or prescription medications for chronic pain.
• Regular monitoring: Frequent follow-ups with a healthcare provider to monitor phosphate levels, bone health, and growth (in children).

Living with X-linked Dominant Hypophosphatemic Rickets

Managing XLH requires a lifelong commitment to treatment and lifestyle adjustments. Here are some practical tips for daily living:

Diet and Nutrition

• Follow a balanced diet rich in calcium and vitamin D. Good sources include dairy products, leafy greens, and fortified foods.
• Avoid excessive caffeine and soda, as they can interfere with calcium absorption.
• Stay hydrated to support kidney function.

Exercise and Physical Activity

• Engage in low-impact exercises like swimming, walking, or cycling to strengthen muscles and bones without putting excessive stress on joints.
• Avoid high-impact activities that increase the risk of fractures.
• Work with a physical therapist to develop a safe and effective exercise plan.

Dental Care

• Visit a dentist regularly for check-ups and cleanings.
• Practice good oral hygiene to prevent abscesses and tooth decay.
• Consider dental sealants or fluoride treatments to protect teeth.

Emotional and Mental Health

• Seek support from counseling or support groups for chronic conditions.
• Educate family, friends, and teachers about XLH to foster understanding and support.
• Encourage children with XLH to participate in activities they enjoy to boost self-esteem.

Prevention

Since XLH is a genetic disorder, it cannot be prevented. However, the following steps can help reduce the risk of complications and manage the condition effectively:

• Genetic counseling: Families with a history of XLH should consider genetic counseling before planning a pregnancy to understand the risks and options (e.g., prenatal testing).
• Early diagnosis: Early detection and treatment can prevent or minimize bone deformities and other complications.
• Adherence to treatment: Strict adherence to medication and supplement regimens is crucial for managing symptoms.
• Regular monitoring: Routine check-ups with a healthcare provider to monitor bone health, growth, and phosphate levels.

Complications

If left untreated, XLH can lead to several complications, including:

• Severe bone deformities: Progressive bowing of the legs, spinal curvature (scoliosis), or other skeletal abnormalities that impair mobility.
• Chronic pain: Persistent bone and joint pain that affects quality of life.
• Dental problems: Severe tooth decay, abscesses, and early tooth loss.
• Hearing loss: Due to abnormalities in the bones of the ear.
• Arthritis: Early-onset osteoarthritis from joint damage.
• Kidney stones: Increased risk due to high calcium levels in the urine (hypercalciuria).
• Enthesopathy: Calcification of tendons and ligaments, leading to pain and stiffness.
• Psychological impact: Anxiety, depression, or social isolation due to chronic pain or physical differences.

Early and consistent treatment can significantly reduce the risk of these complications.

When to Seek Emergency Care

Sources and Further Reading

• National Institutes of Health (NIH) – Genetic and Rare Diseases Information Center: XLH Overview
• Mayo Clinic – Hypophosphatemic Rickets: Mayo Clinic Guide
• Cleveland Clinic – X-Linked Hypophosphatemia: Cleveland Clinic Resource
• XLH Network, Inc.: Patient Support and Advocacy
• FDA Approval of Burosumab (Crysvita): FDA Press Release